View the scientific session presented by ITAC-CME at the 2017 ISTH Congress in Berlin, July 9, 2017.
Adopting New VTE and Cancer Guidelines: Is Clinical Practice Improving?
There is an increased risk of venous thromboembolism (VTE) in cancer patients. In fact, VTE is the most common complication and the second most common cause of death in patients with cancer. Pregnancy and use of hormone therapies can also increase the risk of VTE, which is particularly concerning for women. This case-based educational program has 13 modules, including an up-to-date overview of VTE in women with cancer and 12 challenging clinical scenarios in women with VTE and cancer. Learners will have the opportunity to earn CME credit for each module they choose to complete. All modules include recommendations from the international clinical practice guidelines for the treatment and prophylaxis of VTE in patients with cancer, and provide appropriate treatment and prevention strategies. The educational continuum concludes with a self-reflective exercise, providing learners an opportunity to measure effects of the learning activity on clinical practice for additional credits.
Topics: Hematology, Intensive Care, Oncology
Target Audiences: Oncologists, obstetricians and gynaecologists, and other specialists and family physicians with an interest in thrombosis in women with cancer
Activity Format: Patient case studies
Credits: UEMS: 11 European CME Credits (ECMEC) / McGill University: 13 CME credits (RCPSC MOC Section 1)
Thursday, February 14, 2015
Thrombosis and Cancer in Women accredited lunch symposium, presented by ITAC-CME, held February 14th, 2015 at the 6th International Symposium on Women's Health Issues in Thrombosis and Haemostasis (WHITH), in Berlin, Germany. This symposium was accredited as a single event by the European Council for Continuing Medical Education (EACCME) for up to 2 hours of European external CME credits. The EACCME is an institution of the European Union of Medical Specialists (UEMS).